[go: up one dir, main page]

MX2009009442A - Probioticos para mejorar la microbiota intestinal. - Google Patents

Probioticos para mejorar la microbiota intestinal.

Info

Publication number
MX2009009442A
MX2009009442A MX2009009442A MX2009009442A MX2009009442A MX 2009009442 A MX2009009442 A MX 2009009442A MX 2009009442 A MX2009009442 A MX 2009009442A MX 2009009442 A MX2009009442 A MX 2009009442A MX 2009009442 A MX2009009442 A MX 2009009442A
Authority
MX
Mexico
Prior art keywords
probiotics
gut microbiota
improve gut
improve
medicament
Prior art date
Application number
MX2009009442A
Other languages
English (en)
Inventor
Norbert Sprenger
Marie-Claire Fichot
Karl-Josef Huber-Haag
Florence Rochat
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2009009442A publication Critical patent/MX2009009442A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se describe el uso de Bifidobacterium lactis CNCM I-3446 en la fabricación de un medicamento o composición nutricional terapéutica para promover el desarrollo de una microbiota intestinal bifidogénica temprana en infantes nacidos por cesárea.
MX2009009442A 2007-03-28 2008-03-27 Probioticos para mejorar la microbiota intestinal. MX2009009442A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105074A EP1974743A1 (en) 2007-03-28 2007-03-28 Probiotics to Improve Gut Microbiota
PCT/EP2008/053611 WO2008116892A1 (en) 2007-03-28 2008-03-27 Probiotics to improve gut microbiota

Publications (1)

Publication Number Publication Date
MX2009009442A true MX2009009442A (es) 2009-09-14

Family

ID=38051788

Family Applications (4)

Application Number Title Priority Date Filing Date
MX2009009318A MX2009009318A (es) 2007-03-28 2008-03-27 Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
MX2009009931A MX2009009931A (es) 2007-03-28 2008-03-27 Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.
MX2009009442A MX2009009442A (es) 2007-03-28 2008-03-27 Probioticos para mejorar la microbiota intestinal.
MX2009010252A MX337667B (es) 2007-03-28 2008-03-27 Combinacion simbiotica para mejorar la microbiota intestinal.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2009009318A MX2009009318A (es) 2007-03-28 2008-03-27 Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
MX2009009931A MX2009009931A (es) 2007-03-28 2008-03-27 Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009010252A MX337667B (es) 2007-03-28 2008-03-27 Combinacion simbiotica para mejorar la microbiota intestinal.

Country Status (15)

Country Link
US (4) US20100119488A1 (es)
EP (6) EP1974743A1 (es)
CN (4) CN101652080A (es)
AU (4) AU2008231778A1 (es)
BR (4) BRPI0809626A2 (es)
CA (4) CA2678994A1 (es)
ES (2) ES2434566T3 (es)
MX (4) MX2009009318A (es)
MY (1) MY151137A (es)
PL (2) PL2131859T3 (es)
PT (2) PT2131859T (es)
RU (4) RU2009139667A (es)
UA (2) UA97662C2 (es)
WO (4) WO2008116916A1 (es)
ZA (3) ZA200907541B (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
AU2007222598B2 (en) 2006-03-07 2013-01-10 Société des Produits Nestlé S.A. Synbiotic mixture
WO2007144334A1 (en) * 2006-06-13 2007-12-21 Nestec S.A. Prevention and treatment of otitis media with non-pathogenic bacterial strains
EP2147678A1 (en) * 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
CN102231957A (zh) * 2008-12-05 2011-11-02 雀巢产品技术援助有限公司 用于低出生体重婴儿的组合物
EP2206506A1 (en) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
WO2016026684A1 (en) 2014-08-18 2016-02-25 Nestec S.A. Prebiotics for reducing the risk of obesity later in life
WO2011012655A1 (en) * 2009-07-31 2011-02-03 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
DK2289527T3 (en) 2009-08-25 2018-04-23 Nestec Sa BIFIDOBACTERIUM LONGUM AND FUNCTIONAL GI DISEASES
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
EP2455387A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
US20130280225A1 (en) * 2010-12-29 2013-10-24 Nestec S.A. Fiber and probiotics for reducing intestinal symptoms related to stress
EE05721B1 (et) 2011-02-25 2014-08-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
MY171851A (en) 2011-06-20 2019-11-04 Heinz Co Brands H J Llc Probiotic compositions and methods
EP2797606A4 (en) 2011-08-17 2015-09-30 MicroBiome Therapeutics LLC COMPOSITION AND USE OF A FORMULATION TO INCREASE THE RELATIONSHIP OF GASTROINTESTINAL MICROBOTS IN PLANT STEM BACTERIITIES FOR MICROBOTS OF THE FIRMUCES PLANT STAMM
AU2012324993B2 (en) * 2011-10-18 2015-11-26 Société des Produits Nestlé S.A. Composition for use in the promotion of magnesium absorption and/or magnesium retention
FI3978598T3 (fi) 2011-12-01 2024-11-12 Univ Tokyo Ihmisperäisiä bakteereja, jotka indusoivat regulatoristen t-solujen proliferaatiota tai kertymistä
JP6115094B2 (ja) * 2012-11-15 2017-04-19 株式会社Ｇｓユアサ 蓄電素子及び蓄電素子の製造方法
PT2994150T (pt) 2013-05-10 2019-06-14 Heinz Co Brands H J Llc Probióticos e métodos de utilização
US10940158B2 (en) 2013-11-15 2021-03-09 Societe Des Produits Nestle S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section
CN105682664A (zh) 2013-11-15 2016-06-15 雀巢产品技术援助有限公司 利用岩藻糖基化低聚糖预防或治疗非分泌型母亲诞下或喂养的婴儿的变态反应的组合物，尤其适用于有风险的婴儿或剖腹产婴儿
RU2016123515A (ru) 2013-11-15 2017-12-20 Нестек С.А. Композиции для применения в целях профилактики или лечения некротизирующего энтероколита у детей грудного и младшего возраста
ES2895380T3 (es) 2013-11-15 2022-02-21 Nestle Sa Composiciones para su uso en la prevención o tratamiento de la enterocolitis necrotizante en bebés y niños pequeños
DK3212208T3 (da) * 2014-10-29 2021-05-17 Biogaia Ab Anvendelse af l. reuteri til forebyggelse eller behandling af mikrobiotadysbiose tidligt i livet
EP3294308A4 (en) * 2015-05-14 2019-03-06 University of Puerto Rico PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN
EP3331383B1 (en) 2015-08-04 2021-05-05 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
WO2017043963A1 (en) * 2015-09-11 2017-03-16 N.V. Nutricia Kit of parts for stimulating microbiota health after non-natural birth
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
WO2017129644A1 (en) * 2016-01-26 2017-08-03 Nestec S.A. Compositions with specific oligosaccharides to prevent or treat allergies
KR102844378B1 (ko) * 2016-05-31 2025-08-07 모리나가 뉴교 가부시키가이샤 뇌기능 개선제
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
EP3493686B1 (en) 2016-08-04 2024-03-27 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
EP3618843A1 (en) * 2017-05-05 2020-03-11 Société des Produits Nestlé S.A. Treatment of infant colic
AU2018310705B2 (en) * 2017-08-04 2024-01-18 Societe Des Produits Nestle S.A. Probiotic bacteria preconditioned in a GOS-containing medium and use thereof
US20220010267A1 (en) * 2018-05-30 2022-01-13 Evolve Biosystems, Inc. Compostions and method of use for h5 competent bifidobacterium longum subsp. infantis
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
CN109497271A (zh) * 2018-12-06 2019-03-22 江苏奥迈生物科技有限公司 一种提高断奶仔猪免疫力的复合饲料添加剂及其制备方法
US20220293275A1 (en) * 2019-06-11 2022-09-15 CJ Bioscience. Inc Method for detecting gut dysbiosis of infant
TWI754302B (zh) * 2019-06-21 2022-02-01 大江生醫股份有限公司 乳雙歧桿菌tci604及其代謝產物的應用
CN111053244A (zh) * 2019-12-06 2020-04-24 山东体育学院 一种基于肠道微生物的营养调节方法及系统
CN111296711A (zh) * 2020-03-31 2020-06-19 广州纽缤乐营养科技股份有限公司 一种益生菌固体饮料及其制备方法
EP4180880A1 (fr) * 2021-11-10 2023-05-17 Montres Breguet S.A. Dispositif d'affichage d'une succession d'indications d'une grandeur temporelle pour une pièce d'horlogerie
EP4536010A1 (en) * 2022-06-10 2025-04-16 DSM IP Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
WO2023237687A1 (en) * 2022-06-10 2023-12-14 Dsm Ip Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
EP4619504A1 (fr) 2022-11-17 2025-09-24 Institut National de la Recherche pour l'Agriculture, l'Alimentation et l'Environnement Limosilactobacillus mucosae et désordres nécessitant un accroissement du niveau de glp-1
EP4660294A1 (en) * 2023-02-01 2025-12-10 Beijing Sanyuan Foods Co., Ltd. Breast milk-derived lacticaseibacillus rhamnosus and use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
SU1743607A1 (ru) * 1990-02-05 1992-06-30 2-й Московский государственный медицинский институт им.Н.И.Пирогова Способ профилактики дисбактериоза кишечника у новорожденных детей
DE69223615T2 (de) 1992-07-06 1998-04-09 Nestle Sa Lactobacillus Acidophilus enthaltende Antigastritis-Mittel
DE69219768T2 (de) 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
US20060275895A1 (en) 2003-06-27 2006-12-07 Bio-Circuit Biogas producing facility with anaerobic hydrolysis
EP2108269A1 (en) * 2005-04-13 2009-10-14 Nestec S.A. Infant formula with low dose probiotics and low dose proteins
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
RU2430631C2 (ru) 2006-02-10 2011-10-10 Нестек С.А. Пребиотическая смесь олигосахаридов и пищевой продукт, ее содержащий
AU2007222598B2 (en) * 2006-03-07 2013-01-10 Société des Produits Nestlé S.A. Synbiotic mixture
WO2007144334A1 (en) * 2006-06-13 2007-12-21 Nestec S.A. Prevention and treatment of otitis media with non-pathogenic bacterial strains

Also Published As

Publication number Publication date
ES2577434T3 (es) 2016-07-14
AU2008231763A1 (en) 2008-10-02
EP2129242A1 (en) 2009-12-09
EP2489280A3 (en) 2013-06-26
AU2008231775A1 (en) 2008-10-02
RU2009139669A (ru) 2011-05-10
ZA200907541B (en) 2011-04-28
MX337667B (es) 2016-03-14
CN101652080A (zh) 2010-02-17
RU2009139667A (ru) 2011-05-10
CA2679081A1 (en) 2008-10-02
WO2008116907A1 (en) 2008-10-02
AU2008231778A1 (en) 2008-10-02
WO2008116904A1 (en) 2008-10-02
RU2009139658A (ru) 2011-05-10
WO2008116916A1 (en) 2008-10-02
EP2131859B1 (en) 2016-04-27
UA97662C2 (ru) 2012-03-12
PL2131859T3 (pl) 2016-12-30
UA97663C2 (ru) 2012-03-12
PT2131859T (pt) 2016-07-13
CN101646452A (zh) 2010-02-10
ZA200907731B (en) 2011-04-28
BRPI0809622A2 (pt) 2014-09-16
AU2008231702A1 (en) 2008-10-02
MY151137A (en) 2014-04-30
PT2131680E (pt) 2013-10-28
AU2008231763B2 (en) 2013-10-31
CN101652079A (zh) 2010-02-17
CN101646453A (zh) 2010-02-10
EP2131680B1 (en) 2013-08-14
WO2008116892A1 (en) 2008-10-02
EP2131680A1 (en) 2009-12-16
CA2678994A1 (en) 2008-03-27
MX2009010252A (es) 2009-10-13
MX2009009931A (es) 2009-09-24
RU2456008C2 (ru) 2012-07-20
PL2131680T3 (pl) 2014-01-31
US20100086527A1 (en) 2010-04-08
EP2129393A1 (en) 2009-12-09
ZA200907538B (en) 2011-04-28
EP2489280A2 (en) 2012-08-22
EP2131859A1 (en) 2009-12-16
RU2009139660A (ru) 2011-05-10
ES2434566T3 (es) 2013-12-16
CA2682654A1 (en) 2008-10-02
RU2521500C2 (ru) 2014-06-27
BRPI0809356A2 (pt) 2014-09-02
US20100150874A1 (en) 2010-06-17
MX2009009318A (es) 2009-09-10
EP1974743A1 (en) 2008-10-01
CA2680093A1 (en) 2008-10-02
BRPI0809626A2 (pt) 2014-09-23
US20100119488A1 (en) 2010-05-13
US20100119497A1 (en) 2010-05-13
BRPI0809355A2 (pt) 2014-09-02
AU2008231702B2 (en) 2014-01-16

Similar Documents

Publication Publication Date Title
MX2009009442A (es) Probioticos para mejorar la microbiota intestinal.
MY158816A (en) Probiotics for reduction of risk of obesity
MY159072A (en) Probiotics to increase iga secretion in infants born by caesarean section
MY150657A (en) Reduction of risk of diarrhoea
MY196432A (en) Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
UA100551C2 (en) Synbiotic mixture
JP2009539371A5 (es)
PH12014501749A1 (en) A nutritional composition comprising probiotics and improving sleep patterns
NZ612386A (en) Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
NZ601141A (en) Nutritional formulas containing synbiotics
MX2010005132A (es) Uso de oligosacaridos conteniendo n-acetilactosamina para maduración de las respuestas inmunes en neonatos.
PH12017502182A1 (en) Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
MY169058A (en) Method for stimulating the intestinal flora
IN2014DN03449A (es)
BR112014030434A2 (pt) método não terapêutico; uso de uma proteína; composição nutricional; e uso da composição nutricional
RU2014106509A (ru) Получение и применение бактериального гистамина
MX2016015153A (es) Complementacion de microbioma neonatal.
RU2018139655A (ru) Бифидобактерии для увеличения безжировой массы тела
NZ712603A (en) Composition containing bacterium belonging to genus lactobacillus
CN104366486A (zh) 五联益生菌咀嚼片的配方及制备方法
RU2018139656A (ru) Бифидобактерии для снижения потребления пищи, энергии и/или жиров
RU2009125646A (ru) Способ коррекции микрофлоры кишечника
TH117336A (th) โพรไบโอติกสำหรับลดความเสี่ยงต่อโรคอ้วน
TH144912A (th) การลดความเสี่ยงในการเป็นโรคท้องเสีย
UA35783U (ru) Сухая диетическая смесь

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration